v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (2,096,837) $ (1,988,337)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation 478,611 636,844
Depreciation 4,107
Amortization 6,736 4,786
Gain on sale of short-term investments (21,025) (20,119)
Return on investment in Joint Venture 864
Changes in operating assets and liabilities:    
Accounts receivable 755 (1,040)
Accounts receivable - related party 37,812 (396)
Prepaid assets 3,838 (86,183)
Inventory (48,016) (675)
Accounts payable (76,480) 25,445
Accrued expenses (2,489) 2,597
Net cash used in operating activities (1,712,988) (1,426,214)
Cash flows from investing activities:    
Sale of short-term investments 5,589,606 6,496,000
Purchase of short-term investments (4,000,654) (4,998,663)
Purchase of equipment (49,276)
Purchase of patents (14,065) (20,540)
Purchase of trademarks (15,932) (3,039)
Net cash provided by investing activities 1,509,679 1,473,758
Cash flows from financing activities:    
Proceeds from ATM, net of fees 756,421
Net cash provided by financing activities 756,421
Net increase in cash and cash equivalents 553,112 47,544
Cash and cash equivalents - beginning of period 654,783 574,485
Cash and cash equivalents - end of period 1,207,895 622,029
Non-cash investing and financing activities:    
Unrealized gain on short-term investments $ 88 $ 830